Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors. (Q53159452)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 July 2012
edit
Language Label Description Also known as
English
Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors.
scientific article published on 2 July 2012

    Statements

    title
    Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    22753585
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753585%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    6 February 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q53159452&oldid=2143923826"